Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

180.54 -0.13 (-0.07%)

Streaming Delayed Price Updated: 12:20 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

3 Cheap Stocks to Buy Now for Fast Gains ↗

February 22, 2024

Dive into the world of investing with cheap stocks DaVita, Altria, and StoneCo as they show potential growth.

Via InvestorPlace

Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details ↗

February 20, 2024

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.

Via Benzinga

DaVita Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

February 20, 2024

Via Benzinga

3 Top-Rated Stocks To Buy After Comfortably Surpassing Earnings Expectations ↗

February 16, 2024

This week’s earnings lineup has featured several top-rated stocks that have added to this optimistic growth narrative and here are a few to consider

Via Talk Markets

Why DaVita Stock Popped Today ↗

February 14, 2024

The dialysis services company handily beat expectations with its latest quarter.

Via The Motley Fool

Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday ↗

February 14, 2024

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

DaVita: Q4 Earnings Insights ↗

February 13, 2024

Via Benzinga

DaVita (DVA) Q4 2023 Earnings Call Transcript ↗

February 13, 2024

DVA earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Time To Buy These High Growth Stocks As Earnings Approach ↗

February 13, 2024

This week’s earnings lineup will be highlighted by several growth stocks with none standing out more than Airbnb and DaVita

Via Talk Markets

Meet the Most Ridiculously Cheap Stock in Warren Buffett's Berkshire Hathaway Portfolio ↗

February 12, 2024

This stock isn't cheap because it's performed poorly over the past 12 months.

Via The Motley Fool

2 Best Warren Buffett Stocks to Buy for the Long Haul ↗

February 09, 2024

You don't need to have millions of dollars to invest in quality businesses.

Via The Motley Fool

Earn a 5.79% Dividend Yield from DaVita Stock Using This Hack ↗

January 31, 2024

Via Benzinga

Don't Overlook These Top Value Stocks In January It's Time To Buy ↗

January 12, 2024

Investors searching for value will want to pay attention to a few top-rated stocks that are standing out among the finance and medical sectors

Via Talk Markets

In-Depth Technical Analysis of DAVITA INC. ↗

January 08, 2024

DAVITA INC (NYSE:DVA) has a strong technical rating of 9 out of 10, indicating a potential breakout.

Via Chartmill

Bull of the Day: DaVita ↗

December 30, 2023

Most anybody who works in healthcare is familiar with the company and its services which include 2,707 outpatient centers in 46 states, as well as 351 centers in 11 countries worldwide.

Via Talk Markets

DaVita Inc. (NYSE: DVA) Highlighted for Surprising Price Action

November 13, 2023

Via Investor Brand Network

Earnings Scheduled For February 13, 2024 ↗

February 13, 2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

Via Benzinga

DaVita Earnings Preview ↗

February 12, 2024

Via Benzinga

Healthcare Sector Stocks: Consistent Above-Average Growth And Income ↗

December 18, 2023

The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.

Via Talk Markets

5 Undervalued Stocks In The S&P 500 ETF To Buy For 2024 ↗

December 11, 2023

After several twists and turns, the S&P 500 has hit a series of new 2023 highs lately, driven by the optimism that the Fed is done with interest rate hikes.

Via Talk Markets

Topics ETFs Economy Stocks

Only Have $100? 3 No-Brainer Stocks to Buy Right Now ↗

November 28, 2023

The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.

Via InvestorPlace

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

DaVita: Q3 Earnings Insights ↗

November 07, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 08, 2023

Via Benzinga

DaVita (DVA) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

DVA earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

Buffett’s Bullish Bets: 3 Stocks Where Warren Has At Least a 25% Stake ↗

October 24, 2023

A man who likes to make big bets on businesses, these Warren Buffett stocks are his biggest ones without actually owning the business.

Via InvestorPlace

3 Stocks to Buy From the ‘Buy the Dip’ ETF ↗

October 23, 2023

It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.

Via InvestorPlace

Topics Artificial Intelligence

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review ↗

October 13, 2023

The major indexes stalled at key levels amid weak breadth.

Via Investor's Business Daily

Novo Nordisk's Kidney Outcomes Trial Has Broad Industry Implications ↗

October 12, 2023

Novo Nordisk A/S (NYSE: NVO) shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.